Leen Ann M. 13D/13G Filings for Marker Therapeutics, Inc. (MRKR)

Leen Ann M. 13D and 13G filings for Marker Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-03-23
7:45 pm
Sale
2021-03-16 13D Marker Therapeutics, Inc.
MRKR
Leen Ann M. 241,584
2.890%
-30,000decrease
(-11.05%)
Filing